Foundation Venture Capital Group, LLC
Impact investorPrinceton · Pre-Seed–Series A · 5 people tracked
Investment thesis
Foundation Venture Capital Group practices impact investing focused on New Jersey's health-related technology sector. It provides pre-seed and seed capital to early-stage startups emerging from affiliated research organizations, aiming to generate measurable social impact while advancing innovations toward commercialization. Beyond capital, it offers nonmonetary support including strategic, operational, and back-office assistance beginning before incorporation and continuing through the company's life cycle until traditional venture funding becomes viable. Gains from investments are reinvested to fund further research and innovation at affiliated organizations. The firm also helps portfolio companies connect with traditional venture capital partners to further commercialize their discoveries for patient benefit.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directories
What they invest in
from 7 of 15 portfolio companiesBiotech ×7Healthtech ×5Digital Health ×2Medical Devices ×2AI & Machine Learning ×1Mental Health ×1New Materials ×1
HQs:United States×4
Investments · 15 tracked
founders shown can be your intro pathBy year:2023 · 12019 · 12 dated
NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries.
BiotechHealthtechMedical DevicesMonmouth Junction, US
Charles J. Gatt, Jr., MD(Founder & CEO)Michael G. Dunn, PhD(Founder & Secretary/Treasurer)Kevin Weadock, PhD(Chief Operating Officer)
Zena Therapeutics is a therapeutics company developing drug candidates, with work spanning molecular design, pharmacology, animal studies, and clinical trial design toward IND submission.
BiotechHealthtechMental HealthPrinceton, US
Eileen Carry, PhD(Founder)inEileen Carry(Chief Scientific Officer | co-Founder)Ariane Vasilatis(Chief Executive Officer | co-Founder)
Biopharmaceutical company developing Leukothera-based therapeutics for blood cancers, autoimmune/inflammatory diseases, and HIV.
BiotechKendall Park, US
BENJAMIN BELINKA(Executive Officer, Director)JAMES GOLUBIESKI(Director)PETER ALFF(Director)SCOTT KACHLANY(Director)
Developing blood tests to detect neurodegenerative diseases at early stages; Foundation sold its equity interest to Breakthrough Diagnostics, LLC.
Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease.
AI & Machine LearningBiotechDigital Health
First spin-out from Hackensack Meridian Health Research Institute, developing a platform for targeted capture of extracellular vesicles to enable earlier detection of tumors and other diseases.
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investors7G BioVentures
Focused on longevity technologies; Foundation sold its equity interest to Rostock International, Ltd.
Repurposing a clinically approved drug to treat L-Dopa Induced Dyskinesia in Parkinson's disease patients.
NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
BiotechDigital HealthHealthtechMedical Devices
Mark(Associate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School)Martin(Chief Executive Officer)
Spinout of Cooper University HealthCare developing a multi-directional vascular access system enabling antegrade and retrograde access through a single entry point.
Designs mental health and addiction medications aimed at minimizing misuse and preventing overdose fatalities.
Exits · 1
IPOs and acquisitions across the tracked portfolioVisikolacq. by MatTek (BICO Group)
Frequently asked questions
- How many investments has Foundation Venture Capital Group, LLC made?
- Foundation Venture Capital Group, LLC has 13 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does Foundation Venture Capital Group, LLC invest at?
- Foundation Venture Capital Group, LLC invests at the Pre-Seed, Seed, Series A stages.
- What is Foundation Venture Capital Group, LLC's typical check size?
- Foundation Venture Capital Group, LLC typically writes checks of $500K.
- What sectors does Foundation Venture Capital Group, LLC focus on?
- Foundation Venture Capital Group, LLC focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices, Mental Health.
- Where is Foundation Venture Capital Group, LLC located?
- Foundation Venture Capital Group, LLC is headquartered in Princeton, US.
Similar investors
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies focused exclusively on mental and neuro health.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
Equitage Ventures is an early-stage investor providing capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.